UWMC vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 29, 2026

UWMC

59.0
AI Score
VS
UWMC Wins

CLOV

39.1
AI Score

Investment Advisor Scores

UWMC

59score
Recommendation
HOLD

CLOV

39score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric UWMC CLOV Winner
Forward P/E 3.1279 37.7358 UWMC
PEG Ratio 0 0 Tie
Revenue Growth -70.6% 55.6% CLOV
Earnings Growth 277.8% 0.0% UWMC
Tradestie Score 59.0/100 39.1/100 UWMC
Profit Margin -1.3% -0.7% CLOV
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY UWMC

Relative Price Performance (Last 90 Days)

UWMC 1M: -13.1% · 3M: -42.7% CLOV 1M: +1.9% · 3M: -13.4%

Current Technical Phase

UWMC

Markdown
Sell / avoid

Price below a falling SMA50 (slope -17.5%), weak momentum, RSI 43

RSI (14): 43.0 · Price: $1.26

CLOV

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -3.2%) with fading momentum, RSI 48

RSI (14): 47.6 · Price: $4.38

Fundamentals Snapshot

Metric UWMC CLOV
Market Cap — —
Forward P/E 3.6 29.2
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.7% 0.6%
Gross Margin 1.0% 0.2%
Operating Margin -1.1% 0.0%
EPS -0.10 -0.05
Dividend Yield 0.34% —

Frequently Asked Questions

Based on our detailed analysis, UWMC is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.